[Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003523:Cycloserine / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000494:pharmacology; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D014586:USSR
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
Epidemiologicheskoe, mikrobiologicheskoe i klinicheskoe znachenie pervichnoĭ lekarstvennoĭ ustoĭchivosti mikobakteriĭ tuberculeza (kollektivnoe issledovanie)